news aktuell GmbH

HACKATAO X CRYPTO STAMP ART: AUSTRIAN POST PRESENTS NEW “CRYPTO STAMP ART” WITH SOULBOUND TOKEN AND AUTHENTICITY CERTIFICATE

Share
The four Crypto stamp art designs: Empress Elisabeth of Austria, Sisi Skull, Emperor Franz Joseph I of Austria, Franz Skull
The four Crypto stamp art designs: Empress Elisabeth of Austria, Sisi Skull, Emperor Franz Joseph I of Austria, Franz Skull Credit: Austrian Post

Austrian Post issues its new Crypto stamp art (CSA). The limited special edition by renowned Italian artist duo Hackatao is immortalised and secured on the blockchain and it’s also the first time a Soulbound token has been used as a certificate of authenticity. Crypto stamp art focuses on works by renowned digital artists, making it a coveted collector’s item for crypto investors, art enthusiasts and philatelists.

INSPIRED BY AUSTRIAN HISTORY

The four motifs are inspired by Austrian history: Empress Sisi and Emperor Franz Joseph – each in a ‘living’ and ‘dead’ version. “In death, we are all equal”: This stamp combines Austrian tradition with modern technology and tells the story of a life full of tragedy, romance, and wanderlust.

The animated digital versions come in different rarity grades – from Danube Blue to Imperial Red. Particularly rare digital ‘misprints’ are also hidden in the collection. The physical and digital versions are forever linked by a Soulbound token, making a wallet-to-wallet transfer impossible.

 CRYPTO-ART PIONEERS

“We were intrigued by this project because it allowed us to engage with something as institutional as the Postal Service and become part of the history of a form of collecting that runs parallel to the crypto art world. Being part of a collection that embodies such a rich history moved and inspired us. The Austrian Post is an OG in this NFT space, just as we are. They stand out as an institution and for its educational efforts, making the Web3 world more accessible to a traditional audience”, said artist duo Hackatao.

Available in selected post offices, the Crypto stamp online shop (shop.crypto.post.at/en) and via the collector’s service (phone: +43 577 67 – 95095; email: sammler-service@post.at).

More information: cryptostamp.com

Contacts

Images

The four Crypto stamp art designs: Empress Elisabeth of Austria, Sisi Skull, Emperor Franz Joseph I of Austria, Franz Skull
The four Crypto stamp art designs: Empress Elisabeth of Austria, Sisi Skull, Emperor Franz Joseph I of Austria, Franz Skull
Credit: Austrian Post
Download

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Vyoma’s first Space Domain Awareness satellite has reached orbit13.1.2026 12:34:15 CET | Press Release

Munich, 13. January 2026 - Vyoma, a Germany-based company providing Space Domain Awareness (SDA) capabilities, has launched its pioneering surveillance satellite, Flamingo-1, on Sunday, January 11th, 2026 from Vandenberg Space Force Base, California, USA. It was launched aboard the Twilight rideshare mission with SpaceX via Germany-based launch integrator Exolaunch. The satellite was deployed to its operational Sun-synchronous orbit of approximately 500-km in altitude. This marks a significant achievement for the company, which patented the operational concept of an optimized SDA mission. Flamingo-1, equipped with an optical sensor for space-based space surveillance, is a gamechanger for Europe, strengthening SDA efforts directly from orbit. The advanced optical instrument will detect, track and characterize space objects, such as debris and other satellites. Crucially, it will allow Vyoma and its customers to follow up on manoeuvring objects and derive insights into adversary actions

Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press Release

Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye